Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred Yung

Showing results (11-20 of 217) with videos related to

Pageof 22
Sort By:
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
Current therapies for glioblastomaW K Alfred Yung
Current Medicine (Cham, Switzerland)|June 8, 2022
Inaugural editorialSonglin Wang, Alfred Yung
Neuro-Oncology|November 5, 2008
Moving toward the next steps in angiogenesis therapy?W K Alfred Yung
Neuro-Oncology|August 20, 2011
New impact factor number reflects sustained and enhanced growthW K Alfred Yung
Neuro-Oncology|April 27, 2013
From GWAS risk foci to glioma molecular subclassW K Alfred Yung
Neuro-Oncology|January 4, 2013
Year brings higher impact factor, more submissions for Neuro-OncologyW K Alfred Yung
Neuro-Oncology|October 15, 2014
Imaging endpoints in brain tumor clinical trials: proceedings of the January 30, 2014 Workshop. IntroductionW K Alfred Yung
Neuro-Oncology|September 24, 2013
New Neuro-Oncology Practice journal to launch in 2014Susan Chang, W K Alfred Yung
Neuro-Oncology|September 9, 2008
Bevacizumab--news from the fast lane?Michael Weller, W K Alfred Yung
Neuro-Oncology|July 19, 2013
Angiogenesis inhibition for glioblastoma at the edge: beyond AVAGlio and RTOG 0825Michael Weller, W K Alfred Yung
Pageof 22

Showing results (11-20 of 217) with videos related to

Sort By:
Pageof 22
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
Current therapies for glioblastomaW K Alfred Yung
Current Medicine (Cham, Switzerland)|June 8, 2022
Inaugural editorialSonglin Wang, Alfred Yung
Neuro-Oncology|November 5, 2008
Moving toward the next steps in angiogenesis therapy?W K Alfred Yung
Neuro-Oncology|August 20, 2011
New impact factor number reflects sustained and enhanced growthW K Alfred Yung
Neuro-Oncology|April 27, 2013
From GWAS risk foci to glioma molecular subclassW K Alfred Yung
Neuro-Oncology|January 4, 2013
Year brings higher impact factor, more submissions for Neuro-OncologyW K Alfred Yung
Neuro-Oncology|October 15, 2014
Imaging endpoints in brain tumor clinical trials: proceedings of the January 30, 2014 Workshop. IntroductionW K Alfred Yung
Neuro-Oncology|September 24, 2013
New Neuro-Oncology Practice journal to launch in 2014Susan Chang, W K Alfred Yung
Neuro-Oncology|September 9, 2008
Bevacizumab--news from the fast lane?Michael Weller, W K Alfred Yung
Neuro-Oncology|July 19, 2013
Angiogenesis inhibition for glioblastoma at the edge: beyond AVAGlio and RTOG 0825Michael Weller, W K Alfred Yung
Pageof 22